Dr. Li Ou is currently the Vice President at Genemagic Bio, a startup focused on AAV gene therapy for neurological and ocular diseases. Previously, Li was Associate Director of Gene Therapy at Capsida Biotherapeutics and Assistant Professor at the University of Minnesota, USA. Li obtains his PhD in Genetics (minor in Biostatistics) at the University of Minnesota. He has over 10 years of experience in leading IND-enabling studies of gene therapy (AAV, lentivirus, ZFN, CRISPR, gene regulation), resulting in 2 IND approvals, 6 pending patents, 26 manuscripts, 63 abstracts, and 23 oral presentations.
